New York, London, Bermuda, 11th December 2007 - Celtic Pharma, the global private equity firm focused on the development of pharmaceuticals and biological drugs, today announces that the firm’s principals, Stephen Evans-Freke and John Mayo CBE, are to launch two new follow-on funds targeting the pharmaceutical industry’s need for well developed products. Celtic Pharma’s first fund, Celtic Pharmaceutical Holdings L.P., is now over 75% committed and, once new transactions that have agreed term sheets and are in legal documentation have been completed, will be fully invested.
